The Liberian government Monday announced that the nation's Deputy Chief Medical Doctor Abraham Borbor, who was recently injected with the anti-Ebola trial drug, ZMAPP, has died.
Minister of Information Lewis Brown disclosed this to reporters in Monrovia, the West African country's capital city, although the late doctor was able to walk around Sunday and his doctors were hopeful that he would make a full recovery, Xinhua reported.
Meanwhile, another doctor, Phillip Zokonis Ireland, who was in isolation along with Borbor, was discharged last week after he tested negative.
Updating on progress by government on Ebola virus disease sensitisation, Brown said community residents are now actively involved and the dissemination of Ebola messages is encouraging.
The minister added that the government has conducted a two-day awareness workshop in various communities to determine the response of citizens indicating that the people are now better positioned in the fight to prevent spread of the virus.
Brown told reporters that four protestors involved in the recent disturbances at the West Point Township quarantined site have tested positive to the Ebola virus disease.
Minister Brown said the government has set up a team to conduct investigation into the skirmishes in West Point after the areas were quarantined last week that led to the death of one person and injuries to several others.
Brown said Vice President Joseph Boakai would visit another quarantined Ebola isolation centre in Dolo town while President Ellen Johnson Sirleaf would visit the West Point quarantined Ebola centre.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
